Unstable angina and non-ST elevation acute coronary syndrome - Epidemiology and current management in Japan (Japan Multicenter Investigation for Cardiovascular Disease-D (JMIC-D) Committee)

Circulation Journal

Volumn 71, Issue 9, 2007, Pages 1335-1347

  Yui, Yoshiki ^a   Hirayama, Atsushi ^b   Nonogi, Hiroshi ^c   Kimura, Kazuo ^d   Kodama, Kazuhisa ^e   Hosoda, Saichi ^f   Kawai, Chuichi ^g  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b SURUGADAI NIHON UNIVERSITY HOSPITAL   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^d YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^e Amagasaki Central Hospital   (Japan)

^f SAKAKIBARA HEART INSTITUTE   (Japan)

^g TAKEDA GENERAL HOSPITAL   (Japan)

Author keywords

Acute coronary syndromes; Epidemiology; Non ST elevation; Unstable angina

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ANGINA, UNSTABLE; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; MYOCARDIAL REVASCULARIZATION; QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548481542     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1335     Document Type: Article

References (19)

1. Statistics and Information. Department of the Minister's Secretariat of the Ministry of Health, Labour and Welfare. Population and Vital Statistics of Japan in 2003.
2. Yamaguchi T, Ishikawa K, Isshiki T, Ino T, Kanmatsuse K, Kitamura S, et al. Guidelines for management of acute coronary syndrome without persistent ST segment elevation (JCS 2002). Circ J 2002; 66(Suppl IV): 1123-1163.
3. Sueda S, Ochi N, Kawada H, Matsuda S, Hayashi Y, Tsuruoka T, et al. Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetylcholine. Am J Cardiol 1999; 83: 1186-1190.
4. Kawai C, Yui Y, Hosoda S, Nobuyoshi M, Suzuki S, Sato H, et al. A prospective, randomized, double-blind multicenter trial of a single bolus injection of the novel modified t-PA E6010 in the treatment of acute myocardial infarction: Comparison with native t-PA. J Am Coll Cardiol 1997; 29: 1447-1453.
5. ACA/AHA 2002 Guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: Summary Article. J Am Coll Cardiol 2002; 40: 1366-1374.
6. Yamamoto T, Yasutake M, Takagi H, Akutsu K, Fujita N, Kasagami Y, et al. Impact of the revised criteria for acute myocardial infarction using cardiac troponins in Japanese population with acute coronary syndromes. Circ J 2005; 69: 774-779.
7. Ogawa A, Seino Y, Yamashita T, Ogata K, Takano T. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST-elevation vs non-ST-elevation acute coronary syndrome. Circ J 2006; 70: 1372-1378.
8. Marrugat J, Elosua R, Marti H. Epidemiology of ischemic heart disease in Spain: Estimation of the number of cases and trends from 1997 to 2005. Rev Esp Cardiol 2002; 55: 337-346.
9. ARIAM Group. Paradoxical effect of smoking in the Spanish population with acute myocardial infarction or unstable angina. Chest 2004; 125: 831-840.
10. Herlitz J, Karlson BW, Sjolin M, Lindqvist J. Ten year mortality in subsets of patients with an acute coronary syndrome. Heart 2001; 86: 391-396.
11. BLIT Investigators. Epidemiology of acute myocardial infarction in the Italian CCU network: The BLITZ study. Eur Heart J 2003; 24: 1616-1629.
12. James SK, Lindback J, Tilly J, Siegbahn A, Venge P, Armstrong P, et al. Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revasucularization in acute coronary syndromes: A GUSTO-IV substudy. J Am Coll Cardiol 2006; 48: 1146-1154.
13. PARAGON-B Investigators. Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndrome. Circulation 2002; 105: 316-321.
14. FRISC II Investigators. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomized multicenter study. Lancet 1999; 354: 708-715.
15. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000; 101: 1102-1108.
16. Kandzari DE, Tcheng JE, Gersh BJ, Cox DA, Stuckey T, Turco M, et al; CADILLAC Investigators. Relationship between infarct artery location, epicardial flow, and myocardial perfusion after primary percutaneous revascularization in acute myocardial infarction. Am Heart J 2006; 151: 1288-1295.
17. Karlson BW, Herlitz J, Hjalmarson A. In consecutive patients hospitalized with acute myocardial infarction, infarct location according to routine electrocardiogram is of minor important for the outcome. Clin Cardiol 1995; 18: 385-391.
18. Ross AM, Cho S, Lundergan CF, Reiner JS, Walker P, Simoons ML, et al. The survival advantage of early complete reperfusion (TIMI grade 3) after infarction coubles between 30 days and 2 years. Circulation 1995; 92: I-718.
19. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000; 36: 1202-1209.